- Methane-reducing feed ingredient Bovaer® ready for US market launch
- dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024
- Share repurchase program to cover share plans completed
- dsm-firmenich Q1 2024 trading update
- Progress on share repurchase program to cover share plans
- dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans
- dsm-firmenich announces repurchase of 1.5m shares to cover share plans
- Ad Hoc Press Release - Regulated Information
- dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China
More ▼
Key statistics
As of last trade DSM-Firmenich AG (DSFIR:AEX) traded at 104.90, -5.58% below its 52-week high of 111.10, set on May 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 106.25 |
---|---|
High | 106.75 |
Low | 104.45 |
Bid | 104.80 |
Offer | 104.85 |
Previous close | 106.55 |
Average volume | 305.93k |
---|---|
Shares outstanding | 265.68m |
Free float | 66.89m |
P/E (TTM) | -- |
Market cap | 28.31bn EUR |
EPS (TTM) | -- |
Annual div (ADY) | 4.10 EUR |
---|---|
Annual div yield (ADY) | 3.85% |
Div ex-date | May 09 2024 |
Div pay-date | May 16 2024 |
Data delayed at least 15 minutes, as of May 29 2024 12:44 BST.
More ▼